The DIA 2024 Global Annual Meeting invites industry, regulators, governments, academics, innovators, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in San Diego, DIA 2024 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.
Join TransCelerate for the sessions:
- “Individual Participant Data Return: Feasible, Personal, and Actionable Options to Support Informed Decision-Making” with Jean Sposaro (BMS).
- “The Need and Case for a Paradigm Shift in Adverse Event Reporting – And Possible Ways Forward” with Andrew Bate (GSK), Mayur Patel (AstraZeneca), and Phil Tregunno (MHRA).
- “Unleashing Biopharma Potential: Maximizing Consortia Engagement with Strategic Change Management” with John Dobbins (TransCelerate), John Sun (Novartis), Toni Spears (Sanofi), and Sarah Tremethick (Roche).
- “How Will the Increasing Use of Real-World Evidence for Regulatory Decision-Making Impact QA Strategies and GCP Inspections?” with Abi Seifert (Novartis), L’Oreal Walker (FDA), and Lee H. Pai-Scherf (FDA).